Lansoprazole Hexal

Lansoprazole, the active ingredient in Lansoprazole Hexal, is a proton pump inhibitor presented as an oral tablet for oral use. It reduces gastric acid secretion and is prescribed for conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome. GNH USA supplies Lansoprazole Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole is a proton pump inhibitor used to reduce gastric acid production in several acid‑related disorders.

- Gastro‑oesophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing by decreasing gastric acidity. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumors.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhoea: loose stools that may resolve with continued therapy. - Abdominal pain: discomfort or cramping in the stomach area. - Nausea: feeling of sickness without vomiting. - Flatulence: increased gas production. - Constipation: infrequent or hard stools.

Serious or Rare Side Effects: - Severe allergic reactions: anaphylaxis, angioedema, or skin rash. - Clostridioides difficile infection: severe colitis presenting with watery diarrhoea. - Low magnesium levels: may cause muscle cramps, seizures, or cardiac arrhythmia. - Bone fractures: increased risk with long‑term use. - Elevated liver enzymes: indicating possible hepatic injury. - Stevens‑Johnson syndrome: rare but life‑threatening skin disorder.

Before initiating therapy, consider the following precautions: - Assess renal and hepatic function: dose adjustment may be needed in impairment. - Use cautiously in elderly patients: higher incidence of adverse events. - Monitor magnesium levels during prolonged treatment: supplement if deficient. - Avoid abrupt discontinuation: taper to prevent rebound acid hypersecretion. - Use with caution when combined with warfarin: monitor coagulation parameters. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Lansoprazole may interact with several medicines; awareness of the interaction level is essential.

Major Interactions (Avoid): - Atazanavir, ketoconazole, itraconazole: reduced absorption of these agents due to increased gastric pH. - Clopidogrel: decreased activation leading to reduced antiplatelet effect. - HIV protease inhibitors (e.g., nelfinavir): diminished efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring closer monitoring. - Digoxin: possible increase in serum levels. - Methotrexate: reduced renal clearance may raise toxicity risk. - Oral contraceptives: may lower hormonal effectiveness, advise additional contraception.